Evidence map›Paper›PMID 11309492›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

Thymocyte-targeted overexpression of xiap transgene disrupts T lymphoid apoptosis and maturation.

D Conte, P Liston, J W Wong, K E Wright, R G Korneluk

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. FAIM-L is an IAP-binding protein that inhibits XIAP ubiquitinylation and protects from Fas-induced apoptosis.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  3. Fas death receptor signalling: roles of Bid and XIAP.Cell death and differentiation · 2012
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. IAPs: what's in a name?Molecular cell · 2008
    Review
  11. Article
  12. Article
  13. Molecular pharmacodynamics in childhood leukemia.International journal of hematology · 2003
    Review
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

D ConteChildren's Hospital of Eastern Ontario, 401 Smyth Road, Ottawa, ON K1H 8L1, Canada.
P Liston
J W Wong
K E Wright
R G Korneluk
Children's Hospital of Eastern Ontario · CAUniversity of Ottawa · CAAegera Therapeutics (Canada) · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The X-linked inhibitor of apoptosis (XIAP) and other members of the inhibitor of apoptosis (IAP) family can suppress apoptosis induced by a diverse variety of triggers. Functional studies done to date have focused on tissue culture models and adenovirus overexpression of XIAP and other IAP proteins. Here we report the phenotype of an engineered transgenic mouse overexpressing a human IAP, as well as assessing the long-term consequence of IAP overexpression. We document the relative protein expression levels of the endogenous mouse homologue to XIAP, mouse inhibitor of apoptosis (MIAP 3), within thymocyte and T cell subpopulations. The consequence of lymphoid-targeted overexpression of XIAP in transgenic mice suggests a physiological role for the endogenous protein, MIAP3. Xiap-transgenic mice accumulated thymocytes and/or T cells in primary and secondary lymphoid tissue, T cell maturation was perturbed, and transgenic thymocytes resisted a variety of apoptotic triggers both in vitro and in vivo. These observations imply a possible key function for the intrinsic cellular inhibitor XIAP in maintaining the homeostasis of the immune system.

Indexed as

ApoptosisAnimalsCD8-Positive T-LymphocytesCell DifferentiationDexamethasonefas ReceptorHomeostasisHumansInhibitor of Apoptosis ProteinsLymphocyte CountLymphocyte Specific Protein Tyrosine Kinase p56(lck)MiceMice, TransgenicOrgan SpecificityPromoter Regions, GeneticProteinsBirc4 protein, mouseDexamethasonefas ReceptorInhibitor of Apoptosis ProteinsLymphocyte Specific Protein Tyrosine Kinase p56(lck)ProteinsXIAP protein, humanX-Linked Inhibitor of Apoptosis Protein

Identifiers

PMID11309492
PMCPMC33161
OpenAlexW2009128649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.